In the News: New Pharma Antitrust Guidelines; Chinese Government Introduces Guidelines to Improve VC Funds Management; and Curbs on Online Military Information

China increases regulatory framework for the pharma and life sciences sectors; Chinese authorities intervene to regulate VC funds management; and internet content providers could face stricter scrutiny on military-related content.

generic drugs



New Antitrust Guidelines Broaden Scope of Regulation of the Pharma Sector


The Chinese State Council released the Anti-Monopoly Guidelines for the Pharmaceutical Sector (关于药品领域的反垄断指南) which took effect on January 24. The Guidelines provide a comprehensive framework for China's antitrust regulator, the State Administration for Market Regulation (SAMR), according to Jones Day.

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]